A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320
about
Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastasesUsing the Promise of Sonodynamic Therapy in the Clinical Setting against Disseminated Cancers.Management of solitary and multiple brain metastases from breast cancerManagement of acquired resistance to epidermal growth factor receptor kinase inhibitors in patients with advanced non-small cell lung cancerAdvances in treatment of brain metastases from primary non-small cell lung cancerSystemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.Increased survival with the combination of stereotactic radiosurgery and gefitinib for non-small cell lung cancer brain metastasis patients: a nationwide study in Taiwan.Survival was Significantly Better with Surgical/Medical/Radiation Co-interventions in a Single-Institution Practice Audit of Frameless Stereotactic RadiosurgeryBrain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis.Efficacy and safety of antitumor agents plus radiotherapy compared with radiotherapy alone for brain metastases from lung cancer.Current approaches to the treatment of metastatic brain tumours.A comparative analysis of EGFR mutation status in association with the efficacy of TKI in combination with WBRT/SRS/surgery plus chemotherapy in brain metastasis from non-small cell lung cancer.Whole brain radiotherapy plus concurrent chemotherapy in non-small cell lung cancer patients with brain metastases: a meta-analysis.Variable dose interplay effects across radiosurgical apparatus in treating multiple brain metastases.Phase II trial of sunitinib as adjuvant therapy after stereotactic radiosurgery in patients with 1-3 newly diagnosed brain metastases.Outcome of gamma knife radiosurgery for metastatic brain tumors derived from non-small cell lung cancer.Unsanctifying the sanctuary: challenges and opportunities with brain metastases.Radiotherapy plus EGFR TKIs in non-small cell lung cancer patients with brain metastases: an update meta-analysis.The Globalization of Cooperative Groups.Evaluation on efficacy and safety of tyrosine kinase inhibitors plus radiotherapy in NSCLC patients with brain metastases.The Influence of Biomarker Mutations and Systemic Treatment on Cerebral Metastases from NSCLC Treated with Radiosurgery.The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastasesPrognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic Irradiation.Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma.Icotinib as initial treatment in lung adenocarcinoma patients with brain metastasesAnalysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasisSpine Stereotactic Body Radiotherapy Outcomes in Patients with Concurrent Brain Metastases.Targeted therapies in brain metastases.Methods and results of locoregional treatment of brain metastases in patients with non-small cell lung cancer.Systemic treatment of non-small cell lung cancer brain metastasesA Neuro-oncologist's Perspective on Management of Brain Metastases in Patients with EGFR Mutant Non-small Cell Lung Cancer.Targeted drugs in combination with radiotherapy for the treatment of solid tumors: current state and future developments.Brain metastasis: new opportunities to tackle therapeutic resistance.Stereotactic radiosurgery (SRS) for brain metastases: a systematic review.Chemotherapy and biological treatment options in breast cancer patients with brain metastasis: an update.Brain metastases in non-small-cell lung cancer: better outcomes through current therapies and utilization of molecularly targeted approaches.Systemic therapy of brain metastases.The Rationale for Targeted Therapies and Stereotactic Radiosurgery in the Treatment of Brain Metastases.Brain metastasis and treatment.The future of targeted therapies for brain metastases.
P2860
Q26768667-03EACFE6-0615-4457-B1D5-7728FA9EB40BQ26784162-DBADDE75-826F-44B9-86CF-43008F235F4AQ26865562-533180FB-3D25-4257-9138-A17DE8F95EFCQ26865779-79C931CA-2B73-4BB3-8BFA-5B64AA61DE50Q27022452-D6D65F45-73FE-4E10-B7FA-0398C778BB28Q30239901-103F6D86-1AA4-41FC-9326-3FA173BD4F89Q30279226-9093641C-0748-4B79-8F36-3860C7BEE361Q30381004-9FF7F1A9-2246-4F7C-A23B-A377DD8644C5Q33430404-8E9BD75D-DC73-4751-963B-CB50AD2C4DE4Q33599135-1C2C13B4-9CB4-4063-90EE-63C721046965Q33696559-86D8E5CA-751C-47E0-B6DC-43744E972736Q34387448-4EAC29B2-4E5B-4F6D-9ABD-E10B0FB89CD6Q34408494-300421C0-4542-4644-8255-30450328FEAEQ34430417-850A77A1-0C32-48D2-896E-9BCEDEA6141BQ35738135-62312E3D-5E62-4B57-9165-CC1C4B8F8B74Q35776489-126E209F-B624-4623-B93A-71FA091872C0Q35788631-C645C2B4-EE25-4064-997E-A5E49F1057B4Q35962441-CBE4CBBF-4113-43BA-AF52-755218BF94B9Q36119749-F7D8A263-4ACE-4FC4-A871-D7A1733F16D1Q36140948-202433EC-513B-466A-94A7-7104DA3FDB02Q36243003-7E1F4233-C9F8-4A5C-A81A-CDD5C2DF4C42Q36244603-50A819D6-2FB9-445C-81A2-CFB4722F5270Q36924250-635BFE21-181A-43B6-93AF-8070F151AC12Q36924484-7786FFCE-B616-4919-93D3-9AF68512927CQ37060391-C7F7461E-3914-4627-A78E-D9153AD9EBECQ37119867-92489537-0304-4BAB-ABCB-F8F252484395Q37175437-6381BA93-0852-4FC6-82EF-BAFB50E0EA70Q37491460-8BBDA752-CE3B-481C-ADEA-CCF2A362BB73Q37727637-A4847CDF-E1C2-409D-A5B4-63CC77C1A19BQ37727648-9259F8AC-4E48-41F9-99A7-620F4102D17EQ37742623-B8622546-C87F-4117-A370-A72836FCCA4CQ38155932-D2EF211A-2602-4648-8145-76A9EF30F181Q38222247-FCBCEAFE-782D-4A0B-A990-3D87942F31EDQ38228670-E6E5F1FA-AE65-496B-A4B5-3015690FCFDAQ38230553-6278FB59-C64E-483D-B8FC-9F1A37433EF1Q38233149-DD78DA75-5603-4FD1-BA5C-14CA630C93DEQ38285931-A0FC4D9B-C823-4C15-9152-E228CBD2BD2EQ38289478-E8B86AD8-3BC8-4A2F-BEDE-307305B6ACC5Q38314890-A9883B34-D6BF-4851-9D30-47F34040BF80Q38564085-E8FC69F8-BBE3-444F-9E9E-9D8979554158
P2860
A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A phase 3 trial of whole brain ...... on Therapy Oncology Group 0320
@en
A phase 3 trial of whole brain ...... n Therapy Oncology Group 0320.
@nl
type
label
A phase 3 trial of whole brain ...... on Therapy Oncology Group 0320
@en
A phase 3 trial of whole brain ...... n Therapy Oncology Group 0320.
@nl
prefLabel
A phase 3 trial of whole brain ...... on Therapy Oncology Group 0320
@en
A phase 3 trial of whole brain ...... n Therapy Oncology Group 0320.
@nl
P2093
P2860
P50
P1476
A phase 3 trial of whole brain ...... on Therapy Oncology Group 0320
@en
P2093
Deepak Khuntia
H Ian Robins
John H Suh
Lucien A Nedzi
Luis Souhami
Mark K Buyyounouski
Meihua Wang
Michael C Schell
Paul W Sperduto
P2860
P304
P356
10.1016/J.IJROBP.2012.11.042
P407
P577
2013-02-04T00:00:00Z